• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于生物信息学分析鉴定和验证肝细胞癌的关键基因。

Identification and Validation of Key Genes in Hepatocellular Carcinoma by Bioinformatics Analysis.

机构信息

Department of Molecular Medicine and Cancer Research Center, Chongqing Medical University, Chongqing, China.

Department of Bioinformatics, Chongqing Medical University, Chongqing, China.

出版信息

Biomed Res Int. 2021 Feb 23;2021:6662114. doi: 10.1155/2021/6662114. eCollection 2021.

DOI:10.1155/2021/6662114
PMID:33688500
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7925030/
Abstract

Hepatocellular carcinoma (HCC) is the most frequent primary liver cancer and has poor outcomes. However, the potential molecular biological process underpinning the occurrence and development of HCC is still largely unknown. The purpose of this study was to identify the core genes related to HCC and explore their potential molecular events using bioinformatics methods. HCC-related expression profiles GSE25097 and GSE84005 were selected from the Gene Expression Omnibus (GEO) database, and the differentially expressed genes (DEGs) between 306 HCC tissues and 281 corresponding noncancerous tissues were identified using GEO2R online tools. The protein-protein interaction network (PPIN) was constructed and visualized using the STRING database. Gene Ontology (GO) and KEGG pathway enrichment analyses of the DEGs were carried out using DAVID 6.8 and KOBAS 3.0. Additionally, module analysis and centrality parameter analysis were performed by Cytoscape. The expression differences of key genes in normal hepatocyte cells and HCC cells were verified by quantitative real-time fluorescence polymerase chain reaction (qRT-PCR). Additionally, survival analysis of key genes was performed by GEPIA. Our results showed that a total of 291 DEGs were identified including 99 upregulated genes and 192 downregulated genes. Our results showed that the PPIN of HCC was made up of 287 nodes and 2527 edges. GO analysis showed that these genes were mainly enriched in the molecular function of protein binding. Additionally, KEGG pathway analysis also revealed that DEGs were mainly involved in the metabolic, cell cycle, and chemical carcinogenesis pathways. Interestingly, a significant module with high centrality features including 10 key genes was found. Among these, CDK1, NDC80, HMMR, CDKN3, and PTTG1, which were only upregulated in HCC patients, have attracted much attention. Furthermore, qRT-PCR also confirmed the upregulation of these five key genes in the normal human hepatocyte cell line (HL-7702) and HCC cell lines (SMMC-7721, MHCC-97L, and MHCC-97H); patients with upregulated expression of these five key genes had significantly poorer survival and prognosis. CDK1, NDC80, HMMR, CDKN3, and PTTG1 can be used as molecular markers for HCC. This finding provides potential strategies for clinical diagnosis, accurate treatment, and prognosis analysis of liver cancer.

摘要

肝细胞癌(HCC)是最常见的原发性肝癌,预后较差。然而,HCC 发生和发展的潜在分子生物学过程在很大程度上仍然未知。本研究旨在使用生物信息学方法鉴定与 HCC 相关的核心基因,并探讨其潜在的分子事件。从基因表达综合(GEO)数据库中选择了与 HCC 相关的表达谱 GSE25097 和 GSE84005,并用 GEO2R 在线工具鉴定了 306 例 HCC 组织和 281 例相应非癌组织之间的差异表达基因(DEGs)。使用 STRING 数据库构建和可视化蛋白质-蛋白质相互作用网络(PPIN)。使用 DAVID 6.8 和 KOBAS 3.0 对 DEGs 进行基因本体论(GO)和京都基因与基因组百科全书(KEGG)通路富集分析。此外,通过 Cytoscape 进行模块分析和中心性参数分析。通过定量实时荧光聚合酶链反应(qRT-PCR)验证正常肝细胞和 HCC 细胞中关键基因的表达差异。此外,通过 GEPIA 进行关键基因的生存分析。我们的结果表明,共鉴定出 291 个 DEGs,包括 99 个上调基因和 192 个下调基因。我们的结果表明,HCC 的 PPIN 由 287 个节点和 2527 个边组成。GO 分析表明,这些基因主要富集在蛋白质结合的分子功能上。此外,KEGG 通路分析还表明,DEGs 主要参与代谢、细胞周期和化学致癌途径。有趣的是,发现了一个具有高中心性特征的显著模块,其中包含 10 个关键基因。在这些基因中,CDK1、NDC80、HMMR、CDKN3 和 PTTG1 仅在 HCC 患者中上调,引起了广泛关注。此外,qRT-PCR 还证实了这 5 个关键基因在正常人类肝细胞系(HL-7702)和 HCC 细胞系(SMMC-7721、MHCC-97L 和 MHCC-97H)中的上调表达;这些关键基因上调表达的患者生存和预后明显较差。CDK1、NDC80、HMMR、CDKN3 和 PTTG1 可用作 HCC 的分子标志物。这一发现为肝癌的临床诊断、准确治疗和预后分析提供了潜在策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0741/7925030/9eb12c7898f4/BMRI2021-6662114.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0741/7925030/9441f26c5299/BMRI2021-6662114.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0741/7925030/17ae0e536097/BMRI2021-6662114.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0741/7925030/aa55d922956c/BMRI2021-6662114.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0741/7925030/7020c412e48e/BMRI2021-6662114.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0741/7925030/47d927732804/BMRI2021-6662114.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0741/7925030/9eb12c7898f4/BMRI2021-6662114.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0741/7925030/9441f26c5299/BMRI2021-6662114.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0741/7925030/17ae0e536097/BMRI2021-6662114.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0741/7925030/aa55d922956c/BMRI2021-6662114.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0741/7925030/7020c412e48e/BMRI2021-6662114.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0741/7925030/47d927732804/BMRI2021-6662114.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0741/7925030/9eb12c7898f4/BMRI2021-6662114.006.jpg

相似文献

1
Identification and Validation of Key Genes in Hepatocellular Carcinoma by Bioinformatics Analysis.基于生物信息学分析鉴定和验证肝细胞癌的关键基因。
Biomed Res Int. 2021 Feb 23;2021:6662114. doi: 10.1155/2021/6662114. eCollection 2021.
2
Identification of core genes and outcomes in hepatocellular carcinoma by bioinformatics analysis.基于生物信息学分析鉴定肝细胞癌的核心基因和预后标志物。
J Cell Biochem. 2019 Jun;120(6):10069-10081. doi: 10.1002/jcb.28290. Epub 2018 Dec 7.
3
Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.基于生物信息学分析的肝细胞癌预后标志物筛选枢纽基因。
Cell Transplant. 2019 Dec;28(1_suppl):76S-86S. doi: 10.1177/0963689719893950. Epub 2019 Dec 11.
4
Bioinformatics Analysis of Candidate Genes and Pathways Related to Hepatocellular Carcinoma in China: A Study Based on Public Databases.中国肝细胞癌相关候选基因和通路的生物信息学分析:基于公共数据库的研究。
Pathol Oncol Res. 2021 Mar 26;27:588532. doi: 10.3389/pore.2021.588532. eCollection 2021.
5
Identification of 5 Hub Genes Related to the Early Diagnosis, Tumour Stage, and Poor Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma by Bioinformatics Analysis.基于生物信息学分析鉴定与乙型肝炎病毒相关的肝细胞癌早期诊断、肿瘤分期和不良预后相关的 5 个枢纽基因。
Comput Math Methods Med. 2021 Sep 23;2021:9991255. doi: 10.1155/2021/9991255. eCollection 2021.
6
Identification and interaction analysis of key genes and microRNAs in hepatocellular carcinoma by bioinformatics analysis.基于生物信息学分析的肝细胞癌关键基因和微小RNA的鉴定与相互作用分析
World J Surg Oncol. 2017 Mar 16;15(1):63. doi: 10.1186/s12957-017-1127-2.
7
Deciphering the Molecular Complexity of Hepatocellular Carcinoma: Unveiling Novel Biomarkers and Therapeutic Targets Through Advanced Bioinformatics Analysis.解析肝细胞癌的分子复杂性:通过先进的生物信息学分析揭示新的生物标志物和治疗靶点。
Cancer Rep (Hoboken). 2024 Aug;7(8):e2152. doi: 10.1002/cnr2.2152.
8
[Screening core genes and cyclin B2 as a potential diagnosis, treatment and prognostic biomarker of hepatocellular carcinoma based on bioinformatics analysis].基于生物信息学分析筛选核心基因及细胞周期蛋白B2作为肝细胞癌潜在的诊断、治疗及预后生物标志物
Zhonghua Gan Zang Bing Za Zhi. 2020 Sep 20;28(9):773-783. doi: 10.3760/cma.j.cn501113-20200818-00461.
9
Integrated Bioinformatics Analysis for the Screening of Hub Genes and Therapeutic Drugs in Hepatocellular Carcinoma.基于生物信息学的肝细胞癌关键基因及药物筛选的综合分析
Curr Pharm Biotechnol. 2023;24(8):1035-1058. doi: 10.2174/1389201023666220628113452.
10
The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.通过高通量数据的生物信息学分析鉴定肝细胞癌中的关键基因和信号通路。
Med Oncol. 2017 Jun;34(6):101. doi: 10.1007/s12032-017-0963-9. Epub 2017 Apr 21.

引用本文的文献

1
Mitochondrial fission regulator 2 promotes cell proliferation, migration and invasion in hepatocellular carcinoma through regulating PI3K/AKT signaling pathway.线粒体分裂调节因子2通过调控PI3K/AKT信号通路促进肝细胞癌的细胞增殖、迁移和侵袭。
Cell Div. 2025 Jun 25;20(1):16. doi: 10.1186/s13008-025-00160-2.
2
Identification of Potential Hub Proteins as Theragnostic Targets in Hepatocellular Carcinoma through Comprehensive Quantitative Tissue Proteomics Analysis.通过全面定量组织蛋白质组学分析鉴定潜在的枢纽蛋白作为肝细胞癌的治疗诊断靶点
Cancer Inform. 2025 May 14;24:11769351251336923. doi: 10.1177/11769351251336923. eCollection 2025.
3

本文引用的文献

1
CDK1, CCNB1, and CCNB2 are Prognostic Biomarkers and Correlated with Immune Infiltration in Hepatocellular Carcinoma.CDK1、CCNB1 和 CCNB2 是肝癌的预后生物标志物,并与免疫浸润相关。
Med Sci Monit. 2020 Aug 31;26:e925289. doi: 10.12659/MSM.925289.
2
Identification of the association between HMMR expression and progression of hepatocellular carcinoma via construction of a co-expression network.通过构建共表达网络鉴定HMMR表达与肝细胞癌进展之间的关联。
Oncol Lett. 2020 Sep;20(3):2645-2654. doi: 10.3892/ol.2020.11844. Epub 2020 Jul 9.
3
Construction and analysis of a diabetic nephropathy related protein-protein interaction network reveals nine critical and functionally associated genes.
Statistical and machine learning based platform-independent key genes identification for hepatocellular carcinoma.
基于统计和机器学习的肝细胞癌平台无关关键基因识别
PLoS One. 2025 Feb 5;20(2):e0318215. doi: 10.1371/journal.pone.0318215. eCollection 2025.
4
Detection of reproducible liver cancer specific ligand-receptor signaling in blood.血液中可重复性肝癌特异性配体-受体信号传导的检测
Front Bioinform. 2025 Jan 9;4:1332782. doi: 10.3389/fbinf.2024.1332782. eCollection 2024.
5
Identification of key genes and signalling pathways in clear cell renal cell carcinoma: An integrated bioinformatics approach.透明细胞肾细胞癌关键基因和信号通路的鉴定:一种综合的生物信息学方法。
Cancer Biomark. 2024;40(1):111-123. doi: 10.3233/CBM-230271.
6
The role of Cyclin Dependent Kinase Inhibitor 3 () in promoting human tumors: Literature review and pan-cancer analysis.细胞周期蛋白依赖性激酶抑制剂3()在促进人类肿瘤中的作用:文献综述与泛癌分析。
Heliyon. 2024 Feb 8;10(4):e26061. doi: 10.1016/j.heliyon.2024.e26061. eCollection 2024 Feb 29.
7
Retracted: Identification and Validation of Key Genes in Hepatocellular Carcinoma by Bioinformatics Analysis.撤回:通过生物信息学分析鉴定和验证肝细胞癌中的关键基因。
Biomed Res Int. 2024 Jan 9;2024:9784513. doi: 10.1155/2024/9784513. eCollection 2024.
8
TRIM55 Promotes Proliferation of Hepatocellular Carcinoma Through Stabilizing TRIP6 to Activate Wnt/β-Catenin Signaling.TRIM55通过稳定TRIP6激活Wnt/β-连环蛋白信号促进肝细胞癌增殖。
J Hepatocell Carcinoma. 2023 Aug 3;10:1281-1293. doi: 10.2147/JHC.S418049. eCollection 2023.
9
Bioinformatics prediction and experimental verification identify cuproptosis-related lncRNA as prognosis biomarkers of hepatocellular carcinoma.生物信息学预测和实验验证确定铜死亡相关长链非编码RNA作为肝细胞癌的预后生物标志物。
Biochem Biophys Rep. 2023 Jun 21;35:101502. doi: 10.1016/j.bbrep.2023.101502. eCollection 2023 Sep.
10
Differentially expressed discriminative genes and significant meta-hub genes based key genes identification for hepatocellular carcinoma using statistical machine learning.基于统计机器学习的肝细胞癌差异表达鉴别基因和关键基因的显著元枢纽基因鉴定。
Sci Rep. 2023 Mar 7;13(1):3771. doi: 10.1038/s41598-023-30851-1.
构建和分析糖尿病肾病相关的蛋白质-蛋白质相互作用网络揭示了九个关键的且功能相关的基因。
Comput Biol Chem. 2019 Dec;83:107115. doi: 10.1016/j.compbiolchem.2019.107115. Epub 2019 Aug 30.
4
Prediction and analysis of weighted genes in hepatocellular carcinoma using bioinformatics analysis.基于生物信息学分析预测和分析肝细胞癌中的加权基因。
Mol Med Rep. 2019 Apr;19(4):2479-2488. doi: 10.3892/mmr.2019.9929. Epub 2019 Feb 4.
5
Identification of key genes and pathways in hepatocellular carcinoma: A preliminary bioinformatics analysis.肝细胞癌关键基因和通路的鉴定:一项初步生物信息学分析
Medicine (Baltimore). 2019 Feb;98(5):e14287. doi: 10.1097/MD.0000000000014287.
6
Dysregulation of Nrf2 in Hepatocellular Carcinoma: Role in Cancer Progression and Chemoresistance.肝细胞癌中Nrf2的失调:在癌症进展和化疗耐药中的作用
Cancers (Basel). 2018 Dec 3;10(12):481. doi: 10.3390/cancers10120481.
7
Machine Learning for Integrating Data in Biology and Medicine: Principles, Practice, and Opportunities.用于整合生物学和医学数据的机器学习:原理、实践与机遇
Inf Fusion. 2019 Oct;50:71-91. doi: 10.1016/j.inffus.2018.09.012. Epub 2018 Sep 21.
8
Genomewide identification of a novel six-LncRNA signature to improve prognosis prediction in resectable hepatocellular carcinoma.全基因组鉴定新型六长链非编码 RNA 标志物改善可切除肝细胞癌患者的预后预测
Cancer Med. 2018 Dec;7(12):6219-6233. doi: 10.1002/cam4.1854. Epub 2018 Oct 30.
9
Clinical, Epidemiological and Histopathological Aspects in Patients with Hepatocellular Carcinoma Undergoing Liver Transplantation.接受肝移植的肝细胞癌患者的临床、流行病学和组织病理学特征
Asian Pac J Cancer Prev. 2018 Oct 26;19(10):2795-2802. doi: 10.22034/APJCP.2018.19.10.2795.
10
Bioinformatics identification of crucial genes and pathways associated with hepatocellular carcinoma.生物信息学鉴定与肝细胞癌相关的关键基因和通路。
Biosci Rep. 2018 Nov 9;38(6). doi: 10.1042/BSR20181441. Print 2018 Dec 21.